Not sure where you come up with $2.60 for the November

New Post Public Reply Private Reply Replies (1) Message Board
MarcS RTB #68833
1,081
Not sure where you come up with $2.60 for the November tranche.
Also, the loans prior to the July and November loans did not have a $10 conversion, but a much much lower conversion price.
And, if you read the November 10 loan, the $7.5 million could be paid toward any of the outstanding prior loans.
In fact on page 8 of today's filing it says that:
Quote:
The selling stockholder may convert all or any part the outstanding balance of the March 2020 Note into shares of our common stock at an initial conversion price of $4.50 per share upon five trading days’ notice, subject to certain adjustments and volume and ownership limitations specified in the March 2020 Note.

Note the conversion price of the March loan was $4.50, not $10.
And, on the same page:
Quote:
Between June 26, 2020 and November 24, 2020, we received conversion and redemption notices from the selling stockholder, and applied the November 2020 Debt Reduction Amount to this note resulting in the note being fully satisfied. The Debt Reduction Amount was separately and independently restructured to be settled in shares of common stock. In satisfaction of the conversions, redemption, and Debt Reduction Amount, we paid $950,000 cash and issued shares of common stock totaling 6,412,444 to the selling stockholder, resulting in the note
being fully satisfied and there is no outstanding balance.

Note it says "Between June 26, 2020 and November 24, 2020," so these shares paid off all of the March loan, not merely the $7,500,000 payment reduction.
It appears that the loans prior to July are paid off, which is good, or great news.
And, as to the July and November loans, $7,500,000 of the November loan is paid off, as well, which is good news, too.
As after the $7,500,000 November payment, the only two remaining Fife loans have a $10 conversion, you can't force Fife to accept that price at this time, the $10 conversion price anticipates that the share price is already over $10. So, you negotiate a price higher than the price at the time of the loan (November 10 share price closed $2.02) and lower than currently closed ($4.995). And, assuming that they used yesterday's closing price of $4.68 as we don't know when today the contract was signed today, the average of $2.02 and $4.68, and you have $3.35, not much off of the $3.40 used.
I don't know how you can spin any of this as a negative, but I am sure the shorts will try.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ImmunoForge Sets Sights on BIO-Europe 2026 for New Deals

Updated Category News Views 3

Making Waves with Cutting-Edge Drug Platforms Ah, how time flies in the biotech universe. Here we are, with ImmunoForge prepping to flaunt its high-tech gear at the big show in Cologne: BIO-Europe 2026. The company's aiming to gauge attention with its flashy ELP and LMT platforms, primed and ready for strategic partnerships. ELP: Revolutionizing Drug Delivery You've got...

Continue Reading
Victor Care Networks Explores Transformative Mental Health

Updated Category News Views 3

Connections at the Core of Care Victor Care Network is stepping into the spotlight with a feature on "All Access hosted by Andy Garcia," putting human relationships front and center in mental health support. This ain't just another run-of-the-mill initiative—it’s a deep dive into the bonds that help people when the chips are down. So, what's it all about? Helping...

Continue Reading
Allooloo's AI Zones Transform Financial Services Agent

Updated Category News Views 3

The Allure of AI Agents in Finance Ah, it's a brave new world, my friend. A hundred years ago, the financial services industry relied on flesh-and-blood analysts armed with pens and filing cabinets. Today? It's all about AI agents, and Allooloo Technologies Corp. is at the heart of the action. Just recently, they rolled out specialized zones of record for AI—datasets...

Continue Reading
Honeywell Aerospace Faces Investor Class Action Lawsuit

Updated Category News Views 5

Smoke and Mirrors: Honeywell's Legal Trouble Okay, here's a fun way to start your day: talking lawsuits. Honeywell Aerospace Inc. (NASDAQ:HONA), a name you'd know if you're into aircraft components and avionics, is in hot water. It seems they've been less than transparent about their business prospects, prompting a class action lawsuit from open market purchasers during a...

Continue Reading
Harbour BioMed's Batoclimab Injected Into Myasthenia Market

Updated Category News Views 3

China's Green Light for Batoclimab When a new drug approval hits, particularly in a crucial market like China, it's a big deal. Harbour BioMed's recent go-ahead from the National Medical Products Administration (NMPA) for their Batoclimab injection is no exception. This marks the first full clinical cycle completion of an anti-FcRn treatment for generalized myasthenia...

Continue Reading
Amber Intl Unveils AGM Outcomes, Strategic Moves

Updated Category News Views 2

Diving Into Amber International's AGM Decisions Ah, the hum of shareholder meetings—a fancy little dance of approvals and resolutions! That's exactly what went down on October 23, 2026, for Amber International Holding Limited. A fresh roster, some hefty share awards, and strategic decisions wrapped up their recent annual gathering. Shed the lawyer-speak and let's get...

Continue Reading
Graybar's Integrity Shines: Forbes Honors Trust Again

Updated Category News Views 3

Trust Is Graybar's Secret Sauce Graybar's been hauling the trust trophy back home from Forbes for the second year straight. This ain't just another fleeting accolade—the kind you hang on the office wall without meaning it. What's brewing here is more profound, nestled in the heart of St. Louis and bubbling through its logistics veins. Being named one of Forbes' 2027...

Continue Reading
Oakworth Capital's Strategic Gains: A Deep Dive

Updated Category News Views 2

Oakworth Capital's Big Moves This Quarter Diving right into the Alabama-based Oakworth Capital's latest numbers, they did not pull any punches with a hefty 19% bump in net income. Now, in a world where banking can sometimes feel like riding a porcupine, Oakworth's ability to rise above speaks volumes. They clocked in at $17.2 million net income for the year-to-date period...

Continue Reading
Cole Haan Opens 600th Store, Makes Boston Comeback

Updated Category News Views 6

A Milestone and a Homecoming Who would've thought? Cole Haan, the American staple that seems to draw from an old-world charm and modern flair, is making waves again. They've just hit their 600th store mark—a number not to scoff at, especially when retail's felt the squeeze lately. But it’s not just about another number. It’s about a return, a resounding "we still...

Continue Reading
Sivers Semiconductors Shakes Up Auditors and Incentives

Updated Category News Views 5

Rethinking the Auditing Game Well, what do you know? Sivers Semiconductors just gave the boot to Deloitte AB. Looks like they're rolling out the welcome mat for Ernst & Young AB to scrutinize their books instead. The move, coming hot from the Extraordinary General Meeting, shows they're not messing around with their financial oversight. Maybe it's a bid for fresh...

Continue Reading

Top 5 Most Recently Viewed Articles

Avanos Medical Appoints Camille Chang Gilmore as HR Leader

Updated Category News Views 231

Avanos Medical Welcomes Camille Chang Gilmore Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the medical technology industry renowned for its innovative healthcare solutions, is excited to share the news of Camille Chang Gilmore's appointment as Senior Vice President and Chief Human Resources Officer. This strategic decision underscores Avanos' commitment to...

Continue Reading
Unlocking Efficiency in Convenience Stores with Square 9

Updated Category News Views 152

Empowering Convenience Stores to Thrive The convenience store industry is experiencing robust growth, presenting both opportunities and challenges for business owners. Amidst this evolving landscape, Square 9 Softworks steps up as a knowledgeable ally, offering powerful insights through its latest expert guide designed specifically for C-stores. This essential resource...

Continue Reading
CREATEA Launches Innovative Mighty Mango Beverage Concept

Updated Category News Views 256

Unveiling of CREATEA Mighty Mango Concept Beverage CREATEA is set to turn heads with the introduction of its Mighty Mango beverage at SupplySide Global 2025. This innovative drink combines a unique formula that not only promotes physical performance through creatine but also enhances mental energy with scientifically-supported ingredients. The 12 oz ready-to-drink...

Continue Reading
Performance Brokerage Services Facilitates Mark Chevrolet Sale

Updated Category News Views 204

Performance Brokerage Services Facilitates Dealership Sale Performance Brokerage Services, a leader in dealership buy-sell activities, recently announced the successful sale of Mark Chevrolet. The transition involved Charles Cabana, the former owner, and Bill Golling, associated with the prominent Golling Automotive Group. A Legacy of Service at Mark Chevrolet Mark...

Continue Reading
Dillard's Stock Takes a Hit: Key Insights and Trends

Updated Category News Views 153

Stock Slump: What Gives? Look, I’ve been in this game long enough to know when a company’s got its back against the wall. Dillard’s is feeling the heat, and today it’s clear: the department store operator isn’t exactly riding high on the hog. Their stock, Dillard's (DDS), took a nosedive of 7.18% and is sitting at $599.80. Why? Well, it boils down to mixed...

Continue Reading